Human Papillomavirus Infectious Entry and Trafficking Is a Rapid Process

ABSTRACT Previous studies have indicated that human papillomavirus (HPV) infectious entry is slow, requiring many hours after initial infection for the virus to gain entry into the nucleus. However, intracellular transport pathways typically are very rapid, and in the context of a natural HPV infection in a wounded epithelium, such slow intracellular transport would seem to be at odds with a normal viral infection. Using synchronized cell populations, we show that HPV trafficking can be a rapid process. In cells that are infected in the late S-early G2/M phase of the cell cycle, HPV16 pseudovirion (PsV) reporter DNA gene expression is detectable by 8 h postinfection. Likewise, reporter DNA can be visualized within the nucleus in conjunction with PML nuclear bodies 1 h to 2 h postinfection in cells that are infected with PsVs just prior to mitotic entry. This demonstrates that endosomal trafficking of HPV is rapid, with mitosis being the main restriction on nuclear entry. IMPORTANCE HPV infectious entry appears to be slow and requires mitosis to occur before the incoming viral DNA can access the nucleus. In this study, we show that HPV trafficking in the cell actually is very rapid. This demonstrates that in the context of a normal virus infection, the cell cycle state will have a major influence on the time it takes for an incoming virus to enter the nucleus and initiate viral gene expression.

[1]  Ari Helenius,et al.  Endosome maturation , 2011, The EMBO journal.

[2]  Mario Schelhaas,et al.  Entry of Human Papillomavirus Type 16 by Actin-Dependent, Clathrin- and Lipid Raft-Independent Endocytosis , 2012, PLoS pathogens.

[3]  D. DiMaio,et al.  Vesicular Trafficking of Incoming Human Papillomavirus 16 to the Golgi Apparatus and Endoplasmic Reticulum Requires γ-Secretase Activity , 2014, mBio.

[4]  C. Burd,et al.  Direct Binding of Retromer to Human Papillomavirus Type 16 Minor Capsid Protein L2 Mediates Endosome Exit during Viral Infection , 2015, PLoS pathogens.

[5]  J. Dillner,et al.  Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. , 1996, Virology.

[6]  L. Banks,et al.  SNX17 Facilitates Infection with Diverse Papillomavirus Types , 2012, Journal of Virology.

[7]  D. Lowy,et al.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Lank,et al.  Establishment of Human Papillomavirus Infection Requires Cell Cycle Progression , 2009, PLoS pathogens.

[9]  Mario Schelhaas,et al.  Human Papillomavirus Types 16, 18, and 31 Share Similar Endocytic Requirements for Entry , 2013, Journal of Virology.

[10]  T. Crook,et al.  HPV-16 E7 functions at the G1 to S phase transition in the cell cycle. , 1990, Oncogene.

[11]  Luise Florin,et al.  Identification of a Dynein Interacting Domain in the Papillomavirus Minor Capsid Protein L2 , 2006, Journal of Virology.

[12]  Wim Quint,et al.  The biology and life-cycle of human papillomaviruses. , 2012, Vaccine.

[13]  D. Lowy,et al.  Generation of HPV pseudovirions using transfection and their use in neutralization assays. , 2005, Methods in molecular medicine.

[14]  Rosa Bernardi,et al.  Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies , 2007, Nature Reviews Molecular Cell Biology.

[15]  Lucas Pelkmans,et al.  Large Scale RNAi Reveals the Requirement of Nuclear Envelope Breakdown for Nuclear Import of Human Papillomaviruses , 2014, PLoS pathogens.

[16]  D. Lowy,et al.  Identification of a Role for the trans-Golgi Network in Human Papillomavirus 16 Pseudovirus Infection , 2013, Journal of Virology.